Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes.
about
Polyunsaturated fatty acids in various macroalgal species from North Atlantic and tropical seasSupplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature DataOmega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?Associations of the Ratios of n-3 to n-6 Dietary Fatty Acids With Longitudinal Changes in Depressive Symptoms Among US Women.Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findingsOmega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trialRational approaches to the neurobiologic study of youth at risk for bipolar disorder and suicide.Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.Skin aging and photoaging alter fatty acids composition, including 11,14,17-eicosatrienoic acid, in the epidermis of human skin.Metabolic syndrome and childhood trauma: Also comorbidity and complication in mood disorderEssential fatty acids and the brain.Essential fatty acids and psychiatric disorders.Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levelsFourth revolution in psychiatry - Addressing comorbidity with chronic physical disordersDocosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids.Depression and hip fracture risk: the NHANES I epidemiologic follow-up study.Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?Inadequate levels of essential nutrients in developed nations as a risk factor for disease: a review.Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan.Dietary polyunsaturated fatty acids and anorexia nervosa: is there a link?Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties.The role of atypical antipsychotics in glucose/insulin dysregulation and the evolving role of the psychiatrist in a new era of drug treatment options.Combined application of eicosapentaenoic acid and docosahexaenoic acid on depression in women: a meta-analysis of double-blind randomized controlled trials.From superior adaptation and function to brain dysfunction--the neglect of epigenetic factors.Considerations in the management of bipolar disorder in women.Fat food for a bad mood. Could we treat and prevent depression in Type 2 diabetes by means of omega-3 polyunsaturated fatty acids? A review of the evidence.Clinical trial: marine lipid suppositories as laxatives.The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms.Metabolic syndrome in bipolar disordersManaging psychiatric disorders with antidiabetic agents: translational research and treatment opportunities.Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3?Clinical trials of PUFAs in depression: State of the art.Effects of dietary ratio of n-6 to n-3 polyunsaturated fatty acids on immunoglobulins, cytokines, fatty acid composition, and performance of lactating sows and suckling pigletsDocosahexaenoic acid (DHA) and hepatic gene transcriptionMedical burden in late-life bipolar and major depressive disordersω-3 fatty acid intakes are inversely related to elevated depressive symptoms among United States womenMembrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment.A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.
P2860
Q21245698-C9ECF3F8-037C-420C-8214-D9F80E4EE16DQ26740508-7E66C523-BD74-4382-A45C-33E9F36F918AQ26782982-2470D757-DECB-4324-8ADA-1B7A49187B4BQ27304687-79057038-C3A2-41E3-8434-8A2233D5BE59Q28741691-EBF582F8-4734-4034-A7CC-96EBB01746F3Q30876278-F722CBB3-59CF-4BBF-B882-7B2F268D157FQ31067000-AE0B3BFA-6D85-4D87-B544-4DE41C0738A7Q33661294-E750A95B-E2EF-4FE6-A0F3-76870789C13AQ33679513-16F4C5FB-EC9B-43CA-9B3E-D2F74EEA507BQ33879786-DE91B61D-0D96-43BD-BF00-9179E7DBDE4CQ34047592-994E3ED5-C4D3-4D43-A154-7AB94D70B413Q34194497-A8001162-8592-451D-96AC-AA3EC4886E4CQ34202271-2F567083-5300-4E42-AF89-C2EA8E8B9594Q34315488-3DD936A6-0B4C-4BD6-9C73-31E9AAC28682Q34345204-C511F7CB-EFA8-43A6-B92D-EA4FB3602DD3Q34660464-59A42F7F-715D-423B-82C2-F2AD20607242Q34756982-6E3B18AE-DACC-43FF-BF10-BA1D60AF6A7CQ34762525-9A0D9A2E-ABFD-4AB7-8B5D-FCFAF2402759Q35553073-0F442B82-5DFB-4A4E-804E-C4D62EDC4DC1Q35670890-2C63DA70-03BD-4DE6-8D46-9B35B11167B5Q35746297-BE14896E-59D7-4778-B199-3547F49CE103Q35862864-31A77604-37F3-4115-BDFE-51BB7B01D5B6Q35936267-0563878C-2DC6-458A-888D-282CCED6FDE1Q35954643-F7494FF3-130C-4864-97DE-8E32D4D01D4EQ35991992-1DD3751D-12D8-457F-9C1F-5E4264705B49Q36210979-109AD32B-B823-489E-8804-BA92E456D923Q36293473-6BD9D808-6F6A-47EF-84DA-338856C1777EQ36329877-58688B14-0608-4421-ADC8-3AA5BB06D0AAQ36349761-7E426B1B-6B06-4989-B7D7-B4F9E6FAD8E5Q36400968-D5F2248B-1861-4169-A6ED-40999C285BD8Q36521858-0A1E04BC-2D89-4D85-BC85-705AA8A3B89CQ36542975-6D3DB319-74A2-42B3-A3AB-A93C387661F6Q36637669-A3AA0605-FB2A-46E1-8CBC-E1B43437E083Q36687514-DC8C62C2-C756-4619-ADD5-DC77842D33F1Q36725271-CC0B6B29-151D-4D64-A02B-5C0C3A8A556FQ37113810-7C52BC27-7C17-4861-98F4-C769F5464428Q37229209-CD2A97C6-1E50-4DA6-81D2-4C8BC3B48A57Q37414767-E8245EAE-551F-4B7B-BE7B-1D988738ABF2Q37484086-E2FC4759-AE29-42E2-A8D8-AFBF32295AF7Q37686306-C901893F-C9FA-4279-9579-F79D2EDD364A
P2860
Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Depression and bipolar disorde ...... sis. Possible candidate genes.
@ast
Depression and bipolar disorde ...... sis. Possible candidate genes.
@en
type
label
Depression and bipolar disorde ...... sis. Possible candidate genes.
@ast
Depression and bipolar disorde ...... sis. Possible candidate genes.
@en
prefLabel
Depression and bipolar disorde ...... sis. Possible candidate genes.
@ast
Depression and bipolar disorde ...... sis. Possible candidate genes.
@en
P921
P356
P1476
Depression and bipolar disorde ...... sis. Possible candidate genes.
@en
P2093
Bennett CN
Horrobin DF
P304
P356
10.1054/PLEF.1999.0037
P577
1999-04-01T00:00:00Z